BTIG Rates BrightSpring Health Services (BTSG) buy

BTIG reaffirms its buy rating for BrightSpring Health Services, Inc. with a $90 price target, a 33.12% upside from the current price.

By TradeTexts Research Desk · Published Jun 22, 2026, 9:01 AM EDT · Updated Jun 25, 2026, 10:01 AM EDT

Reviewed by automated data checks against the source data. How we make and check alerts

BTIG rated BrightSpring Health Services, Inc. ($BTSG) "buy" with a $90 price target on June 22, 2026.

Since the rating, $BTSG is up 2.6% after 1 week, up 3.8% after 1 month and down 9.4% to date (from the $67.20 close on Jun 22, 2026).

BTSG BrightSpring Health Services, Inc.

$60.87 +58.52% year to date

Daily close · Oct 16, 2026

Key Points

BTIG reiterated its buy rating for BrightSpring Health Services, Inc. (BTSG) on June 22, 2026, with a price target of $90.
BTIG's $90 price target implies 33.12% upside from BrightSpring Health Services, Inc.'s ($BTSG) current $67.61 share price.
Shares of BTSG traded at $66.25 on Monday, with a market cap of $13 billion and a forward P/E of 31.3.
Insider transactions included sales by executives and a recent buy by Shah Nigam, while analysts remain positive with multiple buy ratings.

Get $BTSG trade alerts by text

We text you when insiders, Congress or big funds trade $BTSG. Free.

Not investment advice. TradeTexts is not a registered investment adviser, and this automated BrightSpring Health Services, Inc. alert may contain errors. Disclosures

BTIG has reiterated its buy rating for BrightSpring Health Services, Inc. (NasdaqGS: BTSG) with a price target of $90. This reaffirmation came on June 22, 2026, as analyst David Larsen expressed continued confidence in the company's prospects.

Analyst rating track record

BTIG vs. the S&P 500

YTD return -14.69% hypothetical

All-time return +39.68% S&P 500 +41.04%

vs. S&P 500 -1.36% behind the index

Hypothetical returns from BTIG's disclosed trades, not real profit or advice. How we model this.

BrightSpring Health Services, Inc. Stock Up 19.1%

Shares of NasdaqGS:BTSG traded near $66.25 on Monday. BrightSpring Health Services, Inc. boasts a market cap of approximately $13 billion and a forward P/E ratio of 31.3. The stock's 52-week range spans from $19.01 to $66.69, with a 50-day moving average of $54.90 and a 200-day moving average of $40.52. The company maintains a current ratio of 1.737 and a quick ratio of 1.356, with a debt-to-equity ratio of 135.679, indicating a moderate level of leverage.

12-month forecast

$BTSG price target

BrightSpring Health Services, Inc. daily closes and this analyst's $90 target. Not advice.

Recent Earnings

BrightSpring Health Services reported revenue of $13.65 billion, reflecting a growth rate of 25.6%. The company achieved a net margin of 2.27% and a return on equity of 9.23%. With an EPS of $0.77, the next earnings report is anticipated on July 31, 2026.

Insider Buying and Selling at BrightSpring Health Services, Inc.

Recent insider transactions at BrightSpring Health Services include a purchase by Shah Nigam of 4,013 shares on June 11, 2026. On June 5, 2026, Chairman, President, and CEO Jon Rousseau sold 260,000 shares. Additionally, Chief of Staff and Senior Vice President, Human Resources, Lisa Nalley, sold 35,000 shares at an average price of $58.75, while also buying 35,000 shares at $6.37.

Analysts Set New Price Targets

On June 22, 2026, BTIG maintained its buy rating with a $90 price target. This follows TD Cowen's buy rating with an $81 target on June 18, and Goldman Sachs initiating a buy rating at $71 on June 8. Morgan Stanley also maintained a buy rating with a $71 target on June 2. The consensus among 16 analysts is a strong buy, with an average target price of $64.75.

About BrightSpring Health Services, Inc.

BrightSpring Health Services, Inc., headquartered in Louisville, Kentucky, operates as a home and community-based healthcare services platform across the United States. The company focuses on delivering pharmacy and provider services within home and community settings, catering to Medicare, Medicaid, and insured populations. BrightSpring offers a range of services, including clinical care, rehabilitation, and medication management, under the leadership of CEO Jon B. Rousseau. Founded in 1974, the company employs around 23,500 people.

Bottom Line

BTIG's reaffirmation of its buy rating and $90 price target reflects continued optimism for BrightSpring Health Services, Inc. Investors closely monitor such analyst ratings and insider transactions to gauge company performance. As a reminder, 13F filings and analyst ratings provide a snapshot of past positions and opinions, which may not reflect the current market view.